7-((naphthalen-2-ylsulfonyl)methyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine

ID: ALA1078343

PubChem CID: 46882711

Max Phase: Preclinical

Molecular Formula: C21H21NO2S

Molecular Weight: 351.47

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=S(=O)(Cc1ccc2c(c1)CCNCC2)c1ccc2ccccc2c1

Standard InChI:  InChI=1S/C21H21NO2S/c23-25(24,21-8-7-17-3-1-2-4-19(17)14-21)15-16-5-6-18-9-11-22-12-10-20(18)13-16/h1-8,13-14,22H,9-12,15H2

Standard InChI Key:  DIBPPQTZLFRDLN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
   12.3284    0.0180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6111    0.4273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6187   -1.2234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3324   -0.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0409    0.4357    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   13.7623    2.5022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7611    1.6778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4799    1.2642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4779    2.9156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9924    2.0859    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.6366    2.8332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8333    3.0169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6345    1.3454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8301    1.1623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1890    1.6801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1880    2.5062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0403    1.2610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7502    0.8539    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.4472   -0.2755    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.9025   -0.8175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8990    0.0108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1810    0.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4662    0.0022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4738   -0.8293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1922   -1.2347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  7  8  1  0
 10 11  1  0
 11 12  1  0
 10 13  1  0
 14 15  1  0
 15 16  1  0
 16 12  1  0
 13 14  1  0
  8 15  2  0
  7 17  1  0
 17  5  1  0
  5  1  1  0
  3  4  2  0
  5 18  2  0
 16  9  2  0
  5 19  2  0
  9  6  1  0
  4  1  1  0
 20 21  1  0
  2 21  1  0
 21 22  2  0
 22 23  1  0
 20  3  1  0
 23 24  2  0
  6  7  2  0
 24 25  1  0
 25 20  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA1078343

   7-(naphthalen-2-ylsulfonylmethyl)-2,3,4,5-tetrahydro-1H-3-benzazepine

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 351.47

Molecular Weight (Monoisotopic): 351.1293

AlogP: 3.50

#Rotatable Bonds: 3

Polar Surface Area: 46.17

Molecular Species: BASE

HBA: 3

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 3

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 9.86

CX LogP: 3.57

CX LogD: 1.17

Aromatic Rings: 3

Heavy Atoms: 25

QED Weighted: 0.79

Np Likeness Score: -0.95

References

1. Bailey JM, Scott JS, Basilla JB, Bolton VJ, Boyfield I, Evans DG, Fleury E, Heightman TD, Jarvie EM, Lawless K, Matthews KL, McKay F, Mok H, Muir A, Orlek BS, Sanger GJ, Stemp G, Stevens AJ, Thompson M, Ward J, Vaidya K, Westaway SM..  (2009)  The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor.,  19  (22): [PMID:19804969] [10.1016/j.bmcl.2009.09.027]

Source

Source(1):

• Scientific Literature